Sepsis cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
m Changes made per Mahshid's request |
||
Line 19: | Line 19: | ||
[[Category:Intensive care medicine]] | [[Category:Intensive care medicine]] | ||
[[Category:Causes of death]] | [[Category:Causes of death]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 18:45, 18 September 2017
![]() |
Resident Survival Guide |
Sepsis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sepsis cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Sepsis cost-effectiveness of therapy |
Risk calculators and risk factors for Sepsis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]
Synonyms and keywords: sepsis syndrome; septic shock; septicemia
Cost-Effectiveness of Therapy[1]
- Total nationwide inpatient annual costs of treating those hospitalized for septicemia have been rising and were estimated to be $14.6 billion in 2008.
- Even with this expenditure, the death rate was high.
- Patients who do survive severe cases are more likely to have negative long-term effects on health and on cognitive and physical functioning.
References
- ↑ "Products - Data Briefs - Number 62 - June 2011". Retrieved 2012-09-17.